Abeona Therapeutics ABEO
NASDAQ ABEO
$4.40 -0.07 (-1.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Gross Margin (2011 - 2026)

Updated

Abeona Therapeutics (ABEO) recorded Gross Margin of 63.30% in Q2 2026, down 5.79 percentage points from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Gross Margin (2011 - 2026) Analysis & Trends

On a TTM basis, Abeona Therapeutics' Gross Margin came in at 67.07% as of Jun 30, 2026; for FY2025, it came in at 73.68%.

  • The Q2 2026 figure is the lowest quarterly Gross Margin since Q1 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 68.12%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 74.74%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 73.54%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 78.02%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 83.60%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 72.04%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 79.76%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 72.78%
10 Abeona Therapeutics 251.30 Mn -462.66 Mn 7.20 Mn 63.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.30%
Mar 31, 2026 69.08%
Dec 31, 2025 80.74%
Dec 31, 2014 100.00%
Sep 30, 2014 100.00%
Jun 30, 2014 100.00%
Mar 31, 2014 100.00%
Dec 31, 2013 100.00%
Sep 30, 2013 96.30%
Jun 30, 2013 88.65%
Mar 31, 2013 94.69%
Dec 31, 2012 93.44%
Sep 30, 2012 90.93%
Jun 30, 2012 90.87%
Mar 31, 2012 96.79%
Dec 31, 2011 91.77%
Sep 30, 2011 94.14%
Jun 30, 2011 75.33%
Mar 31, 2011 38.67%
API Access

Abeona Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ABEO&period=max&api_key=YOUR_API_KEY